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Abstract
The anthrax toxin is a tripartite toxin, where the two enzymatic subunits require the third subunit, the protective antigen
(PA), to interact with cells and be escorted to their cytoplasmic targets. PA binds to cells via one of two receptors, TEM8 and
CMG2. Interestingly, the toxin times and triggers its own endocytosis, in particular through the heptamerization of PA. Here
we show that PA triggers the ubiquitination of its receptors in a b-arrestin-dependent manner and that this step is required
for clathrin-mediated endocytosis. In addition, we find that endocytosis is dependent on the heterotetrameric adaptor AP-1
but not the more conventional AP-2. Finally, we show that endocytosis of PA is strongly dependent on actin. Unexpectedly,
actin was also found to be essential for efficient heptamerization of PA, but only when bound to one of its 2 receptors,
TEM8, due to the active organization of TEM8 into actin-dependent domains. Endocytic pathways are highly modular
systems. Here we identify some of the key players that allow efficient heptamerization of PA and subsequent ubiquitin-
dependent, clathrin-mediated endocytosis of the anthrax toxin.
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Introduction
Bacterial toxins endowed with enzymatic activity generally have
targets, or require co-factors, that reside in the cytoplasm of the
target cell. Such is the case for the anthrax toxin produced by
Bacillus anthracis. It is composed of three independent polypeptide
chains, 2 of which have an enzymatic activity–edema factor (EF)
and lethal factor (LF)–and one, the protective antigen (PA), which
has the ability to interact with the target cell. EF is a calmodulin
dependent adenylate cyclase that must thus reach the cytoplasm to
become active. LF is a metalloprotease that cleaves MAP kinase
kinases, all of which are cytoplasmic [1,2].
EF and LF reach their final destination through the help of PA.
PA binds specifically to two identified anthrax toxin receptors,
tumor endothelial marker 8 (TEM8, also called ANTXR1) and
capillary morphogenesis 2 (CMG2, or ANTXR2), two type I
membrane proteins that share extensive sequence similarity both in
their extracellular and intracellular domains [3,4]. PA, which is
produced by the bacterium as an 83 kDa form (PA83), is processed
into an 63 kDa form, by host enzymes such as the endoprotease
furin [5]. The thus generated PA63 has the capacity to heptamerize
(PA
7mer) into a ring-like structure, which serves as the receptor of EF
and LF [6]. The hetero oligomeric complex–i.e. PA
7mer-EF/LF and
receptors–is then internalized by the cell and delivered to early
endosomes, where PA
7mer undergoes a conformational change that
leads to its membrane insertion and pore-formation (pPA
7mer) [2].
EF and LF are also sensitive to the acidic pH of endosomes, which
leads to their partial unfolding, allowing them to be translocated
through the lumen of the PA channel to the other side of the
membrane [7].
Considering that PA
7mer is the receptor for EF and LF, one
crucial point is that PA should not undergo endocytosis in its
monomeric form, i.e. the enzymatic subunits would fail to be
delivered to the cytoplasm. This is indeed what has been observed
by us and others [8,9] leading to the notion that the anthrax toxin
times its entry into the cells, in particular by triggering the
activation of src-like kinases [10].
We have previously shown that processing of PA leads to a
relocalization of the toxin from the glycerolipid region of the
plasma membrane to lipid rafts [8], where the receptors encounter
the E3 ubiquitin ligase Cbl that modifies a juxtamembranous
lysine of the cytoplasmic tail of the receptors [11]. Ubiquitination
in turn promotes endocytosis of the toxin through a mechanism
that requires the large GTPase dynamin [8,12]–involved in
vesicles fission, but not the caveolar proteins caveolin-1, pointing
towards a role for clathrin in anthrax toxin endocytosis [8].
We here sought to identify other molecular players involved in
anthrax toxin uptake. We show that clathrin is, as predicted,
involved in endocytosis but that the anthrax toxin follows a non-
canonical clathrin-dependent route that depends of b-arrestins and
the heterotetrameric adaptor complex AP-1. Moreover we show
that endocytosis is strongly actin dependent, in contrast to
endocytosis of another bacterial toxin, diphtheria toxin. Interest-
ingly we found that actin also promotes the heptamerization of
PA63, but only when it is bound to TEM8, not when bound to
CMG2.
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Endocytosis of the anthrax toxin is clathrin mediated
Previous studies of our laboratory indicated that anthrax toxin
endocytosis in HeLa cells is independent of caveolin-1 but was
affected by the overexpression of dominant negative mutants of
dynamin 2 or of the accessory protein Eps15 [8]. Here we sought
to confirm these findings using an independent method, namely
gene silencing by RNAi, to more precisely define the molecular
players involved in anthrax toxin endocytosis.
As mentioned, PA63 heptamerizes at the cell surface in to
PA
7mer, which is an SDS-sensitive complex. Upon arrival in
endosomes, PA
7mer converts to an SDS-resistant form (pPA
7mer),
which is transmembrane. Although formation of pPA
7mer is a late
event, which occurs only after sorting of the toxin-receptor
complex into the intraluminal vesicles of multivesicular endosomes
[13], monitoring formation of pPA
7mer as a function of time is a
convenient read-out to identify factors that affect toxin endocy-
tosis. As shown in Fig. 1A, RNAi against either CHC or dynamin
2 strongly delayed the formation of the pPA
7mer in HeLa cells,
whereas RNAi against Eps15 had no effect, despite efficient
silencing of protein expression (Fig. S1A). We believe that the
discrepancy between our present findings based on RNAi and our
previous conclusions based on over-expression of dominant
negative Eps15 is due to the fact that inhibition of either
transferrin or PA endocytosis required strong over-expression,
which might have been somewhat toxic [8]. Moreover, the effect
of Eps15 over-expression was by no means as strong as the one
observed for dynamin, in parallel experiments [8]. Hela cells
express mainly TEM8. The above experiments therefore indicate
that PA is internalized in a clathrin dependent manner when
bound to TEM8. To investigate whether CMG2-mediated PA
uptake is also clathrin dependent, we first made use of Baby
Hamster Kidney (BHK) cells–which strongly express CMG2
(Fig. 1B) but have undetectable levels of TEM8 messenger (not
shown)–and for which a cell line is available that allows the
inducible expression of clathrin heavy chain (CHC) antisense
RNA [14]. Formation of pPA
7mer was strongly delayed in CHC
antisense RNA-expressing BHK cells (Fig. 1C). Since formation of
pPA
7mer is a rather late event, we used a recently established
FACS-based assay to monitor the initial step of endocytosis of the
toxin [10]. PA was pre-bound to BHK cells at 4uC. Cells were
then incubated at 37uC for different times prior to PA labeling at
4uC and FACS analysis. Incubation at 37uC led to a decrease of
surface fluorescence for control cells, indicating that PA had been
internalized but not for the CHC antisense RNA-expressing BHK
cells (Fig. S1B).
To independently confirm the involvement of clathrin in
CMG2-mediated PA endocytosis, we ectopically expressed
CMG2 in Hela cells and performed RNAi against CHC. As
shown in Fig. 1D, ectopic expression of CMG2 markedly
accelerated and increased the formation of pPA
7mer, indicating
that the transfected receptor was mediating PA uptake. This was
confirmed by the fact that immunoprecipitation of V5-tagged
CMG2 led to the co-immunoprecipitation of PA63 and pPA
7mer
(Fig. S1C, left panel). We next performed RNAi against CHC in
these cells and found that formation of pPA7mer was abolished
during the first 45 min (Fig. 1E), indicating that CHC was
implicated not only in TEM8 mediated PA uptake but also
CMG2-mediated uptake.
Clathrin mediated toxin uptake is AP1 and b-arrestin
dependent
Clathrin coated vesicles are composed of three layers: the inner
layer consists of the cargo, the outer layer is composed by clathrin
and the middle layer is composed of adaptor and accessory/
regulatory molecules that link the cargo to the clathrin coat [15].
We here investigated the possible involvement of the heterote-
trameric adaptor complex AP-2–arguably the most widely used
adaptor in the formation of clathrin-coated vesicles at the plasma
membrane [16]–, of AP-1–which mostly operates on the Trans-
Golgi Network and endosomes–, and the adaptor proteins Grb2,
Dab2 and b-arrestins. b-arrestins have been shown to act as
adaptors, linking cargo receptors to clathrin, either directly, or via
AP2 [17]. Their involvement has been shown in particular during
the endocytosis of G-coupled receptors but also single-transmem-
brane receptors, such as the tyrosine kinase IGF-1R [18] or the
Drosophila Notch receptor [19].
Expression of these different adaptors/accessory proteins was
silenced by RNAi, and formation of pPA
7mer, the SDS-resistant
heptameric PA pore, was monitored as a function of time. As a
second read-out, we also monitored the cleavage of the LF target
MEK1, which reveals the delivery of LF to the cytoplasm. RNAi
against CHC and the E3 ligase Cbl were used as positive controls.
All RNAi duplexes were efficient at lowering the expression levels
of the corresponding proteins (Fig. S1A). Due to the high degree of
similarity between b-arrestin-1 and 2, silencing one gene led to a
decrease in the levels of the other. Our studies can therefore not
discriminate between the two forms.
Silencing of Grb2, Dab2 and the m subunit of the AP-2 complex
had no effect on anthrax toxin entry into Hela cells (Fig. 2AB).
The lack of involvement of AP-2 was somewhat surprising, raising
the possibility that AP2 was insufficiently knocked down to see an
effect on endocytosis. We therefore monitored the entry of a
second bacterial toxin, namely diphtheria toxin, which has also
been shown to enter cells via clathrin-mediated endocytosis [20] as
confirmed here (Fig. S2A). Diphtheria toxin is an ADP-ribosylat-
ing toxin that modifies elongation factor 2 thus leading to the
inhibition of protein synthesis [21]. In contrast to the anthrax
toxin, entry of diphtheria toxin was delayed in AP-2, but not AP-1,
RNAi treated cells, when compared to cells treated with an
irrelevant RNAi (Fig. S2B), indicating that silencing of AP-2 was
efficient. It has been previously reported for the EGF-receptor that
the temperature at which the ligand is added to the cells affects the
Author Summary
Bacillus anthracis is the bacterium responsible for the
anthrax disease. Its virulence is mainly due to 2 factors, the
anthrax toxin and the anti-phagocytic capsule. This toxin is
composed of three independent polypeptide chains. Two
of these have enzymatic activity and are responsible for
the effects of the toxin. The third has no activity but is
absolutely required to bring the 2 enzymatic subunits into
the cell where they act. If one blocks entry into the cells,
one blocks the effects of these toxins, which is why it is
important to understand how the toxin enters into the cell
at the molecular level. Here we identified various
molecules that are involved in efficiently bringing the
toxin into the cell. First, we found that the actin
cytoskeleton plays an important role in organizing one
of the two anthrax toxin receptors at the cell surface.
Second, we found a cytosolic protein, b-arrestin, that is
required to modify the intracellular part of the toxin
receptor, to allow uptake. Finally, we directly show, for the
first time, that anthrax toxin uptake is mediated by the so-
called clathrin-dependent pathway, a very modular entry
pathway, but that the toxin utilizes this pathway in an
unconventional way.
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in AP-2 RNAi treated cells still occurred when the ligand was pre-
bound at 4uC, but not when the ligand was added to the cells at
37uC [22]. We therefore repeated our knockdown experiments,
omitting the pre-binding of PA63 at 4uC and adding it directly to
cells at 37uC. In contrast to what was observed for EGF receptor,
we still found that AP-2 depletion had no effect on the formation
of pPA
7mer (Fig. S3A).
In marked contrast to the knock down of AP-2, silencing the m
subunit of the AP-1 adaptor drastically delayed the formation of
the SDS-resistant pPA
7mer and LF-mediated MEK1 cleavage in
Hela cells Fig. 2AB. This was not due to an off-target effect of the
RNAi duplexes, since a similar effect was observed upon silencing
of the c subunit of the AP-1 complex (Fig. S3B). The lack of
pPA
7mer formation was not due to an effect of AP-1 silencing on
endosome acidification–due for example to altered trafficking
of vATPase components–since diphtheria toxin, which as the
anthrax toxin requires transport to an acidic compartment for
cytoplasmic delivery of the enzymatic subunit, retained full activity
in AP-1 depleted cells (Fig. S2B). In addition to a requirement for
AP-1, we found that silencing b-arrestins strongly delayed
formation of pPA
7mer Fig. 2AB. Knowing that Hela cells mainly
express TEM8, the above experiments indicate that TEM8-
mediated uptake depends on AP1 and b-arrestins but not on AP-2.
To investigate whether CMG2-mediated uptake had the same
requirements, we repeated the above experiments in Hela cells
transfected with CMG2. As shown in Fig. 2C, formation of
pPA7mer was not detected within the first 45 min when silencing
AP-1 or b-arrestin, but occurred normally when silencing AP-2,
showing that both receptors have the same adaptor requirements.
Figure 1. Anthrax toxin enter cells by clathrin mediated endocytosis. A: Hela cells were transfected 72 hrs with control siRNAs or siRNAs
against Clathrin Heavy Chain (CHC), the dynamin 2 (Dyn-2) or Epidermal growth factor receptor pathway substrate 15 (Eps 15). Cells were incubated
with 500 ng/ml PA63 for 1 hr at 4uC and different times at 37uC and cell extracts (40 mg of proteins) were analyzed by SDS-PAGE and western blotting
to reveal PA monomer and SDS-resistant heptamer (pPA
7mer). B: Cell extracts (40 mg of protein) from Raw, BHK and Hela–transfected or not with
mouse CMG2-4–cells were analyzed by SDS-PAGE and Western blotting for the expression of CMG2. C: Stable BHK21-tTA/anti-CHC cells maintained in
tetracycline (control cells) or not (CHC AS) were incubated with 500 ng/ml PA63 for 1 hr at 4uC and different times at 37uC and extracts (40 mgo f
proteins) were analyzed by SDS-PAGE and western blotting to reveal PA63 and SDS-resistant heptamer (pPA
7mer). DE: Hela cells were transfected
72 hrs with human CMG2-V5 and with control siRNAs or siRNAs against CHC. Cells were then treated as in A. Cells extracts (40 mg of proteins) were
analyzed by SDS-PAGE and western blotting to reveal the different forms of PA, CMG2-V5 and the N-terminus of the LF target MEK1 (MEK1 (N)).
doi:10.1371/journal.ppat.1000792.g001
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7mer formation
observed in Hela cells depleted in AP-1 or b-arrestins was due to
an effect on the initial step of uptake from the plasma membrane.
We included the Cbl silencing in this analysis since the role of
ubiquitination in the initial uptake of plasma membrane proteins is
somewhat unclear in mammalian cells [23]. Using our FACS
based endocytosis assay, PA was found to remain at the cell surface
upon silencing of the m subunit of AP-1, of b-arrestins as well as of
Cbl, while silencing of the m subunit of AP-2 had no effect (Fig. 3A).
As has been well established, endocytosis of PA requires
heptamerization [1,9]. Therefore the lack of endocytosis of PA
upon RNAi silencing of genes could be due either to an effect on
heptamerization or on endocytosis itself. Heptameric PA at the cell
surface is sensitive to SDS and thus migrates as a monomer on
SDS gels. It can however be converted to an SDS resistant form by
submitting cell extracts to a pH 4.5 treatment. Using this
treatment, we could rule out that silencing of CHC, b-arrestins
or AP-1 affected formation of surface PA
7mer in Hela cells (Fig.
S3C), altogether showing that the endocytosis process itself was
affected upon silencing of these genes.
While the role of AP adaptor complexes in recruiting clathrin to
cargo molecules has been well established, the role of b-arrestins is
less clear [17]. b-arrestins have been proposed to be adaptors
either for clathrin or for E3 ubiquitin ligases to the cargo receptor
Figure 2. Endocytosis of PA is b-arrestin and AP-1 dependent. A-B: Hela cells were transfected 72 hrs with control siRNAs or siRNAs against
Clathrin Heavy Chain (CHC), the ubiquitin ligase E3 Cbl (Cbl), Grb2, AP-1, AP-2, b-arrestin-1 (b-Arr-1), b-arrestin-2 (b-Arr-2) or Dab2. The efficiency of
siRNAs was analyzed on cell extracts (40 mg of proteins) by SDS-PAGE and western blotting (Fig. S1). Cells were incubated with 500 ng/ml PA63 and
100 ng/ml LF for 1 hour at 4uC and different times at 37uC and cell extracts (40 mg of proteins) were analyzed by SDS-PAGE and western blotting to
reveal PA SDS-resistant heptamer (pPA
7mer) and N-terminus of MEK1 (MEK1 (N)). B: Levels of pPA
7mer and full length MEK1 were quantified using the
Typhoon scanner and normalized to 1 and 100% respectively at time 0 (1 hour at 4uC). The plot represents the means of 4 independent experiments.
Errors represent standard deviations. C: Hela cells were transfected 72 hours with CMG2-V5 and control siRNAs or siRNAs against AP-1, AP-2 or b-
arrestin-2 (b-Arr-2). Cell extracts were subsequently analyzed by SDS-PAGE and western blotting to reveal the different forms of PA, CMG2-V5 and N-
terminus of MEK1 (MEK1 (N)).
doi:10.1371/journal.ppat.1000792.g002
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siRNAs against Cbl, AP-1, AP-2, b-arrestin-1 (b-Arr-1), or b-arrestin-2 (b-Arr-2). Cells were treated with 1 mg/ml of PA63 for 1 hr at 4uC (red) and 30 min
at 37uC (blue) and subsequently submitted to FACS analysis. B: Hela cells were transfected 72 hrs with TEM8/1-HA and with control siRNAs or siRNAs
against b-arrestin 2. Cells were then treated or not with 1 mg/ml of PA63 WT for 1 hr at 4uC and different times at 37uC. Immunoprecipitates against
TEM8-HA were analyzed by SDS-PAGE and western blotting against Ubiquitin, TEM8-HA and PA. C: Hela cells were transfected or not for 24 hrs with
TEM8/1-HA. Immunoprecipitates against b-arrestin were analyzed by SDS-PAGE and western blotting against Cbl, TEM8-HA and b-arrestin. D: Hela
cells were transfected 72 hours with human CMG2-HA and with control siRNAs or siRNAs against b-arrestin 2. Cells were then treated or not with
1 mg/ml of PA63 WT for 1 hr at 4uC and different times at 37uC. Immunoprecipitates against CMG2-HA were analyzed by SDS-PAGE and western
blotting against Ubiquitin, CMG2-HA and PA.
doi:10.1371/journal.ppat.1000792.g003
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would affect ubiquitination of TEM8 or CMG2. Two isoforms of
TEM8 have been reported, TEM8-1, which has a long 200 amino
acid cytoplasmic tail, and TEM8-2 which has a short truncated tail
(Fig. S7A). The long form is thought to be the more ubiquitous
form. While silencing of AP-1 had no significant effect on TEM8-1
ubiquitination (Fig. S4), silencing b-arrestins strongly diminished
ubiquitination (Fig. 3B, note that the apparent lack of ubiquitina-
tion in the 40 min is not due to the lower about of TEM8, since
even at higher levels of TEM8, as shown in Fig. S4, no
ubiquitination signal can be detected upon b-arrestin silencing).
That b-arrestins are involved in recruiting Cbl to the anthrax
receptors was further supported by immunoprecipitation experi-
ments. Immunoprecipitation of endogenous b-arrestin indeed led
to the co-immunoprecipitation of Cbl and of TEM8-1-HA, when
transfected (Fig. 3C). Cbl was not detected in immunoprecipita-
tions against an irrelevant protein (not shown). It is worth
mentioning that another E3 ligase known to be involved in
endocytosis of certain transmembrane proteins such as the
epithelial sodium channel [25], namely Nedd4, is not involved
in anthrax toxin endocytosis (Fig. S3B), underlying the specificity
of the E3 ligase Cbl. We similarly found that silencing of b-
arrestin, prevented PA induced ubiquitination of CMG2 upon
ectopic expression in Hela cells (Fig. 3D).
Intracellular delivery of anthrax toxin is actin dependent
To further dissect the mechanisms governing anthrax toxin
endocytosis, we investigated the role of actin. It has previously
been reported that production of cAMP triggered by anthrax
edema toxin is actin dependent [26]. More recently, Mogridge and
colleagues have shown that TEM8-1, but not TEM8-2, interacts
with actin and have proposed that interaction with actin
modulates the affinity for PA, TEM8-2 having a higher affinity
for PA than TEM8-1 [27]. During the course of the present
studies, Garlick et al. identified a 33 residue stretch in the
cytoplasmic tail of TEM8-1 responsible for actin binding and
found that a synthetic peptide encompassing this region could
trigger actin bundling in vitro [27].
We here sought to investigate what the exact role of actin in
anthrax toxin endocytosis could be. Using our FACS based PA
internalization assay, we monitored the effect of the G-actin
sequestering drug Latrunculin A. Whereas PA was rapidly
internalized in controls cells, endocytosis was completely blocked
in latrunculin treated Hela cells (Fig. 4). This was confirmed by the
Figure 4. Latrunculin A inhibits anthrax toxin uptake. Hela cells were treated 45 min at 37uC with or without Latrunculin A prior to addition of
1 mg/ml of PA63 for 1 hr at 4uC (red) followed by different incubation times at 37uC. A: Cells were then submitted to FACS analysis. B: The plot
represents the mean of the percentage of PA at the cell surface for 4 experiments. Errors represent standard deviations.
doi:10.1371/journal.ppat.1000792.g004
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7mer failed to form and MEK1
remained intact (Fig. 5A and Fig. S5).
Involvement of actin in heptamerization of TEM8-bound
PA
As mentioned above, endocytosis of PA requires heptameriza-
tion [1]. To test whether latrunculin treatment affected heptamer-
ization of PA at the cell surface, cell extracts were submitted to
a pH 4.5 treatment, prior to SDS-PAGE. To our surprise,
heptamerization was severely inhibited in latrunculin treated Hela
cells, indicating that the drug had blocked the oligomerization
process (Fig. 5B). This was not due to an effect of latrunculin on
PA heptamerization per se, as will become apparent later.
The involvement of actin in PA63 heptamerization at the
surface of Hela cells was further confirmed by treating cells with
blebbistatin, an inhibitor of myosin II ATPase activity [28].
Although the effect was not as strong as with latrunculin,
blebbistatin significantly inhibited both the appearance of
endosomal pPA
7mer (SDS resistant) and the surface PA
7mer
(converted to SDS resistant by an acid treatment) (Fig. S6).
The above experiments show that the actin cytoskeleton
promotes toxin oligomerization in Hela cells. We next wished to
confirm the findings of Go et al. on the differential ability of
TEM8 isoforms 1 and 2 to interact with actin [29]. Actin could
be readily detected upon immuno-precipitation of HA-tagged
TEM8-1 expressed in Hela cells. We could also co-immunopre-
cipitate the actin nucleating protein talin, its interacting protein
vinculin (Fig. 6A) and the blebbistatin sensitive myosin II heavy
chain 9, MyH9 [30] (Fig. S7B). Since the interaction of TEM8-1
with actin appears to be direct [27], talin, vinculin and myosin II
might be involved in regulating the dynamics of the process, as
suggested by the here-observed effects of blebbistatin. This will
however require further investigation.
In contrast to the observations reported by Go et al. [29], we
could also detect actin in TEM8-2-HA immunoprecipitates, albeit
at far lower levels than for TEM8-1-HA. In agreement with Go
Figure 5. Latrunculin A prevents transport of PA to endosomes
and subsequent cleavage of MEK1. A: Hela cells were treated
45 min at 37uC with or without Latrunculin A, prior to the addition of
500 ng/ml of PA63 and 100 ng/ml LF for 1 hr at 4uC followed by
different incubation times at 37uC. Cell extracts (40 mg of proteins) were
analyzed by SDS-PAGE and western blotting to reveal pPA
7mer, PA63
and the N-terminus of MEK1 (MEK1 (N)). Tubulin is the equal loading
control. B: Cell extracts (40 mg of proteins) described in A were treated
10 min at room temperature with acid buffer pH 4.5 and analyzed by
SDS-PAGE and western blotting to reveal the total heptameric PA63
(PA
7mer) population and PA63 monomer.
doi:10.1371/journal.ppat.1000792.g005
Figure 6. Binding of PA leads to the release of the actin-interacting complex form the cytosolic tail of TEM8. Hela cells were transfected
24 hrs with TEM8/1-HA (ABC) or TEM8/2-HA (B) or CMG2 (B) or constructs CTT (B) or CCT (B) or TEM8/1 Y383C-HA (C). Cells were then treated or not
with 1 mg/ml of PA83 WT (ABC) or mutant resistant to furin cleavage (C) for 1 hr at 4uC. A: Cells were subsequently incubated 5 or 20 minutes at 37uC.
Immunoprecipitates against TEM8-HA were analyzed by SDS-PAGE and western blotting against Actin, Talin, Vinculin, TEM8-HA and PA. B: Cells were
subsequently incubated 10 minutes at 37uC. Immunoprecipitates against HA were analyzed by SDS-PAGE and western blotting against Vinculin, Actin
and HA. C: Cells were subsequently incubated 10 minutes at 37uC. Immunoprecipitates against TEM8-HA were analyzed by SDS-PAGE and western
blotting against Actin, TEM8-HA and PA.
doi:10.1371/journal.ppat.1000792.g006
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in Hyaline fibromatosis syndrome [31,32], affected actin binding,
but in our hands did not abolish it (Fig. 6C). We were however
unable to detect any co-immunoprecipitation of actin with CMG2
(Fig. 6B). This was somewhat surprising considering the high
degree of similarity between the cytoplasmic tails of CMG2 and
TEM8-1 (Fig. S7A). Since the tail of TEM8-1 is some 50 residues
longer than that of CMG2, we generated a truncated TEM8-1
matching the length of CMG2, and found that the ability to
immunoprecipitate actin was unaffected (not shown). We also
constructed chimeric proteins in which the transmembrane and/
or cytosolic tail of CMG2 were replaced by that of TEM8-1 and
found that the cytosolic tail of TEM8-1 is sufficient to confer actin-
binding ability to the proteins (Fig. 6B). Garlick et al. have
narrowed down the actin interacting domain of TEM8-1 with
actin to residues 379 to 411 (DASYYGGRGVGGIKRMEVRW-
GEKGSTEEGAKLE) [27], a stretch that is absent in TEM8-2
but fully conserved, with the exception of a single residue (bold
underlined), in CMG2. Combined, the observations of Mogridge
and ours thus suggest that direct binding of the 379–411 amino
acid stretch to actin must be prevented in CMG2, through regions
that differ from the tail of TEM8-1 (Fig. S7A). The observation
that TEM8-2 can, albeit to a far lesser extend, also interacts with
actin suggest that TEM8 might be able to interact with actin by
more than one way, possibly directly and indirectly via the
interaction with talin, vinculin and myosin II, an interaction that
would also be prevented in CMG2.
The effect of latrunculin A on PA heptamerization prompted us
to evaluate the effect of PA binding on the interaction of TEM8
with actin. Interestingly, when TEM8-1 (WT or Y383C mutant)
was immuno-precipitated from PA83 treated cells, the interaction
with actin, talin and vinculin was strongly diminished Fig. 6AC.
The decreased interaction with actin did not require the
oligomerization of PA63 since it was equally observed when
treating cells with a mutant of PA that is resistant to furin cleavage
and thus remains monomeric (Fig. 6C) [8]. These observations
show that TEM8-1, as well as TEM8-2 albeit to a far lesser extent,
interact with the actin cytoskeleton, but that binding of PA83
releases this interaction. These findings provide a mechanistic
explanation for the observations of Mogridge and colleagues that
the association of TEM8 with the cytoskeleton correlates with
weakened binding to PA [27,29]. They also provide the first
evidence that binding of the toxin to TEM8-1 on the outside of the
cell leads to a conformational change on the cytosolic side,
corresponding to a form of outside-in signaling. Go et al. recently
described inside-out signaling where by actin might govern the
affinity of TEM8 for its ligand [29]. Thus TEM8 is, as integrins,
capable of both inside-out and outside-in signaling.
Receptor mobility and actin dependence
Using fluorescence recovery after photobleaching (FRAP), Go
et al. [29] have shown that the motilities of TEM8-1 and TEM8-2
at the cell surface differ, TEM8-1 being less mobile with a 25%
immobile fraction. The difference between the two isoforms was
however abolished after latrunculin treatment [29]. We made the
same observations after expression of GFP-fusions of these proteins
in Hela cells and FRAP analysis (Fig. 7A for TEM8-1; TEM8-2
not shown). More specifically, the recovery half-life (t1/2)o f
Figure 7. Effect of latrunculin A on the surface mobility of TEM8-1 and CMG2. Hela cells were transfected 48 hrs with TEM8-1-GFP (AC) or
CMG2-GFP (BD) and treated (red curves) or not (blue curves) with Latrunculin A. AB: Cells were submitted to FRAP analysis in the absence of toxin
treatment. CD: Cells were incubated with 3 mg/ml of mutant PA, resistant to furin cleavage and thus defective in heptamerization, at 4uC for 1 hr and
subsequently warmed back to room temperature, in the presence or absence of latrunculin A, for FRAP analysis. Each curve is the average of at least 9
different cells. Error bars represent standard deviations of the mean at each time point.
doi:10.1371/journal.ppat.1000792.g007
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fraction of 3069%. After latrunculin treatment, the immobile
fraction dropped to 1667% and t1/2 decreased to 12.264.9 s. We
extended these analyses to CMG2. As predicted from the
biochemical observations, we found no effect of latrunculin A
treatment on the mobility of CMG2 using FRAP: t1/2 was
13.364.2 s with 969% immobile fraction in control cells vs.
t1/2=1164.2 s in latrunculin treated cell, p=0.21 (Fig. 7B).
FRAP analysis also confirmed the observation that PA binding
alleviates the interaction with actin. When cells were incubated
with the PA, the latrunculin A dependence of t1/2 for TEM8-1 was
indeed strongly reduced (Fig. 7C) and in certain experiments even
abolished. These experiments were performed using the mutant
PA that cannot heptamerize, in order to focus on the effect of toxin
binding, without the complications of oligomerization and
internalization. The residual effect of latrunculin A could be due
to the fact that not all TEM8-1 molecules are occupied by PA, and
this may also account for the variability between experiments
performed on transiently transfected cells, where expression levels
are not tightly controlled. PA binding had not effect on the
latrunculin A dependence of CMG2 mobility as expected from the
biochemical observations (Fig. 7D).
Differential receptor-dependent requirement for actin in
toxin uptake
The differential abilities of TEM8-1, TEM8-2 or CMG2 to
interact with actin suggested that the requirement for actin in toxin
uptake might depend on the receptor used. To test this, we made
use of a CHO mutant cell lines that is devoid of anthrax toxin
receptors (CHO
DATR) and thus defective in toxin binding [8].
These cells were recomplemented with TEM8-1, TEM8-2 or
CMG2 and the formation of the SDS-resistant pPA
7mer was
monitored. To follow the heptamerization process, we also, in a
parallel set of gels, submitted cell extracts to the pH 4.5 treatment
mentioned above, that converts all PA
7mer to an SDS-resistant
form. As expected, recomplementation with TEM8-1 led to the
same observation as in HeLa cells: latrunculin A treatment
prevented heptamerization of PA, thus even after acid treatment,
heptamers could not be detected (Fig. 8A). In cells expressing
TEM8-2, formation of pPA
7mer was also completely blocked by
latrunculin A. When monitoring the heptamerization process
however, it became apparent that latrunculin A affected the
process, but much less than for TEM8-1 (<40% residual
oligomerization, Fig. 8B). Finally, in cells recomplemented with
CMG2, formation of pPA
7mer was again drastically affected by
latrunculin, but in striking contrast to the observations made for
TEM8, surface heptamerization was unaltered (indicating that
latrunculin does not inhibit the heptamerization process per se)
(Fig. 8C). The absence of pPA
7mer, despite normal heptameriza-
tion, indicates that latrunculin A blocked the endocytic process. To
test this directly, we monitored endocytosis of PA in cells
recomplemented with CMG2-GFP using our FACS assay, and
found that indeed latrunculin A blocked endocytosis (Fig. S8).
Altogether these observations show that 1) actin is required for
efficient heptamerization of PA when bound to TEM8-1, to a
lesser extent when bound to TEM8-2, but not when bound to
CMG2; 2) actin is required for the endocytosis of heptameric PA,
probably irrespective of the receptor, as observed for CMG2 and
TEM8-2.
While actin was shown to play an active role in the formation of
endocytic vesicles in yeast [33], the situation is less clear in
mammalian cells. To test whether actin is systematically required
for clathrin-mediated endocytosis, we investigated the effect
of latrunculin on diphtheria toxin entry. As shown in Fig. S2C,
Figure 8. Receptor dependent actin requirements for PA
heptamerization and endocytosis. CHO
DATR cells were transfected
48 hrs with TEM8/1-HA (A) or TEM8/2-HA (B) or CMG2/4-V5 (C) or empty
pCDNA3 plasmid (control). Cells were then treated 45 min at 37uC with
(filled symbols) or without (open symbols) Latrunculin A, prior to the
addition of 500 ng/ml of PA63 and 100 ng/ml LF for 1 hr at 4uC
followed by different incubation times at 37uC. Total cell extracts were
either analyzed directly by SDS-PAGE and western blotting against PA
or first treated 10 min at room temperature with acid buffer to reveal
the total PA63 heptameric population (surface + intracellular: dashed
lines). PA
7mer and pPA
7mer levels were quantified using the Typhoon
scanner and normalized to 1 at the level at time 0 (1 hour at 4uC). The
plot represents the mean of 3 independent experiments. Errors repre-
sent standard deviations.
doi:10.1371/journal.ppat.1000792.g008
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ADP-ribosylation of EF-2, illustrating that clathrin-dependent
endocytosis can be actin independent.
Discussion
The present work provides a more complete view of anthrax
toxin endocytosis and uncovers an interesting and unexpected role
for actin. In the absence of toxin, the two anthrax toxin receptors,
TEM8-1 and CMG2, reside in somewhat different environments.
TEM8 appears to be actively organized in an actin dependent
manner, while CMG2 is either more randomly distributed or
organized in an actin independent manner. Following toxin
binding, processing by furin and oligomerization, the receptor tail
undergoes src-dependent phosphorylation [10] and subsequent b-
arrestin-dependent Cbl-mediated ubiquitination. Ubiquitination
in turn allows endocytosis via a pathway that appears to be
independent of AP-2, Eps15, Grb2, Dab2 (this paper) or AP180
(not shown) but requires the multimeric adaptor AP-1, dynamin,
clathrin and actin.
b-arrestins in clathrin-dependent anthrax toxin
endocytosis
Our previous findings that anthrax toxin endocytosis is
dependent on dynamin, while independent of caveolin [8],
pointed towards a requirement for clathrin. We now show that
silencing of CHC inhibits endocytosis of the toxin. Clathrin-
mediated endocytosis however does not correspond to a unique
entry route but encompassed a collection of internalization
pathways that are linked by the use of the clathrin coat protein.
The last years have indeed revealed a highly flexible system where
each membrane cargo protein recruits, via ‘‘sorting signals’’ in its
cytoplasmic domain, a specific set of adaptors and accessory
proteins that then interact with clathrin [15]. In addition, some
‘‘add on’’ modules [15] maybe allow and modulate interactions
with the actin cytoskeleton (see below).
We had previously shown that ubiquitination of anthrax toxin
receptors is necessary for the formation of pPA7
mers in endosomes
[11]. We had however not determined the step at which
ubiquitination is required, i.e. removal from the plasma membrane
or sorting into intraluminal vesicles of multivesicular endosomes.
Here we show that ubiquitination by Cbl is at least required for the
initial step of endocytosis, much like what has been observed in
yeast. Interestingly, we found that ubiquitination of the receptors
depends on b-arrestins. These adaptor molecules have been
implicated in the endocytosis of G coupled receptors, as well as
single-transmembrane receptors, such as the tyrosine kinase
receptor IGF-1R [18], the Drosophila Notch receptor [19] and
others (for review see [34]). Since the tails of b-arrestins contain
clathrin and AP-2 interaction motifs, they have been proposed to
act as adaptors to bring clathrin to the cargo receptor [17]. Recent
studies in yeast identified a family of arrestin related proteins–so
called ART (arrestin-related trafficking adaptors) proteins–that
mediate endocytosis of specific plasma membrane proteins.
Instead of acting as an adaptor between the receptor and AP-2,
ARTs were shown to act as adaptors for the Nedd4-like E3
ubiquitin ligase Rsp5 [24,35]. Such an adaptor function of
arrestins to recruit ubiquitin ligases has also been proposed for the
b2-adrenergic receptor [17]. It is likely that b-arrestin is important
for recruitment of RING domain containing ligase Cbl to the
cytoplasmic tail of anthrax toxin receptors. b-Arrestin antibodies
indeed precipitated both TEM8-1 and Cbl and depletion of b-
arrestin prevented the Cbl-mediated ubiquitination of TEM8-1.
Combined with the observations in yeast, our findings illustrate
that b-arrestins are able to recruit E3 ligases both of RING (here)
and HECT (in yeast) domain containing E3 ligases.
Role of AP-1 in clathrin-dependent anthrax toxin
endocytosis
Both TEM8-1 and CMG2 contain two YXXF motifs (F: bulky
hydrophobic, http://elm.eu.org/) in their cytoplasmic tails that
are potential interaction sites with heterotetrameric clathrin
adaptors. The surprise was to find a requirement for AP-1, but
not AP-2. The best-described role of AP-1 is in budding of clathrin
coated vesicles from the Trans-Golgi network and endosomes
[36]. Therefore the apparent requirement of AP-1 in anthrax
endocytosis could be due to an indirect effect, such as the surface
delivery of a required component. AP-1 silencing however had no
effect on the level of the anthrax receptors at the cell surface–toxin
binding was unaffected–, nor on endocytosis of diphtheria toxin or
acidification of endosomes. Moreover, this is not the first report for
a role of AP-1 at the cell surface. AP-1 was found to be required
for phagocytosis in macrophages and in Dictyostelium, and was
detected on nascent phagosomes [37] possibly to deliver
membrane. Similarly a requirement for AP-1, but not AP-2, was
found for clathrin-mediated entry of the human bacterial
pathogen Listeria monocytogenes and AP-1 localized to the entering
bacterium [38] again possibly to deliver membrane. Finally, AP-1
was recently found to be able to functionally compensate for AP-2
in mediating the recycling of synaptic vesicles [39]. Although we
cannot fully exclude an indirect effect of AP-1 silencing, our data
combined with that of recent literature do suggest that AP-1 could
play a role in specific types on endocytosis.
Role of actin in anthrax toxin endocytosis
When analyzing the role of actin in anthrax toxin endocytosis,
we found that TEM8-1 driven heptamerization of PA was strongly
affected by actin depolymerizing drugs or inhibitors of the myosin
II motor. Intriguingly, whereas TEM8-1 was found to interact
with actin in control cells, this interaction was lost upon toxin
binding. Our interpretation of these findings is that the cortical
actin cytoskeleton actively organizes TEM8-1 at the cell surface, in
a manner that favors the oligomerization process. Similarly Mayor
and coworker recently found that actin actively organizes GPI-
anchored proteins into domains [40]. We are not insinuating that
GPI-anchored proteins and TEM8-1 reside in similar domains,
was it only because GPI-anchored are well established to associate
with lipid rafts, which is not the case for TEM8-1 at steady state
[8,11]. The similarities between TEM8-1 and GPI-anchored
proteins in terms of actin dependence do however illustrate the
capacity of the cortical cytoskeleton to organize protein domains
within membranes.
A second surprising observation was that whereas latrunculin
led to an increase in the 2 dimensional diffusion coefficient of
TEM8-1 in the plasma membrane (FRAP experiments), it
inhibited heptamerization. The efficiency of oligomerization
depends on the collision probability between receptor bound PA
monomers. Therefore, one would expect that increased motility
would lead to accelerated oligomerization. This was however
not the case, indicating that the actin dependent localization/
organization of TEM8-1 on the membrane is more important for
efficient oligomerization than the ability of this receptor to rapidly
diffuse at the cell surface.
Despite the high degree of similarity between the cytoplasmic tail
of CMG2 and that of TEM8, and in particular the conservation of
the various potential motifs for binding of actin or actin interacting
proteins (multiple potential SH3 binding motifs, profiling binding
motifs and possibly a distant WASP interacting motif, Fig. S7A), we
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totally independent methods (immunoprecipitation, FRAP and PA
heptamerization experiments). Since CMG2 also contains the
stretch of residues found by Garlick et al. [27] to mediate direct
binding of TEM8-1 to actin, it appears that regions of the
cytoplasmic tail of CMG2, that are not conserved in TEM8-1,
might be involved in preventing actin binding at steady state,
possibly to ensure high ligand binding affinity.
The observation that actin promotes PA heptamerization when
the toxin is bound to TEM8-1, but not when bound to CMG2
provides an possible explanation for an issue that has remained
mysterious to us. In vitro studies have shown that the affinity of PA
for the von Willebrand domain of CMG2 is some 3 orders of
magnitude higher than that of PA for the von Willebrand domain
of TEM8 [3,41]. Interestingly, Liu et al. recently reported that the
apparent functional affinity of PA for its receptor is only 10 times
higher for CMG2 than TEM8 [42]. These functional affinities
were obtained by performing toxicity tests. It is interesting to note
that in these assays performed on living cells, the apparent
difference in binding is 100 lower than expected from experiments
on purified von Willebrand domains. Finally when analyzing
endocytosis of the toxin in cellular systems–i.e. in the absence of
competition with an inactive PA mutant, we have not observed
any drastic difference in the kinetics of PA heptamerization or of
MEK1 cleavage between cells expressing TEM8 vs. CMG2. One
speculation to explain these anomalies is that actin promoted
oligomerization partially compensates for the lower affinity of PA
for the von Willebrand domain of TEM8.
In addition to its role in PA heptamerization, we found that
actin is required for the endocytic process, irrespective of the
receptor usage. For large cargoes such as the Vesicular Stomatitis
virus, it has been proposed that since the transport vesicles is only
incompletely coated by clathrin, actin is required to complete the
process [43]. Considering the small size of the anthrax toxin, even
taking into account heptamerization of PA and binding of EF and
LF, partial coating seems somewhat unlikely. In this case, actin
could accelerate the pinching off and detachment of the clathrin
coated vesicle as observed in yeast [15]. Clarifying the role of actin
in clathrin mediated endocytosis in mammalian cells will clearly
require further studies using multiple systems and cargoes.
Concluding remarks
Combined withpreviousreports, our present findings provide the
following sequence of events leading to endocytosis of the anthrax
toxin (Fig. 9). In the absence of toxin, TEM8-1 interacts with the
actin cytoskeleton. This reduces its mobility and leads to some form
of surface organization, all of which is not observed for CMG2.
Upon secretion by the bacterium and diffusion towards target cells,
PA binds to the receptors with an affinity that depends of the
receptor identity (higher affinity for CMG2 than TEM8) and on the
inside-out signaling, mediated by the actin cytoskeleton, that affects
the conformation of the ectodomain of TEM8-1 [29], similar to
what is observed for integrins. Upon toxin binding, interaction
between TEM8 and the actin cytoskeleton is released. Despite this
lost interaction, the actin dependent surface organization/clustering
of TEM8-1 favors the heptamerization of PA63. Heptamerization
leads to the activation of src-like kinases which in turn phosphorylate
the cytoplasmic tail of CMG2 [10], as step that is required for the b-
arrestin mediated Cbl-dependent ubiquitination of the receptors.
The modifications finally allow the recruitment of AP-1 and
Figure 9. Schematic representation of the endocytosis of the anthrax toxin. TEM8-1 is pre-organized at the cell surface by the cortical actin
cytoskeleton while CMG2 is not. Upon PA binding, processing and oligomerization, the toxin receptor complex moves to lipid rafts. There, b-arrestin
mediates the recruitment of the E3 ligase Cbl to the cytoplasmic tail of the receptor. The ubiquinated receptor subsequently recruits the
heterotetrameric adaptor AP-1 and finally clathrin. Completion of the endocytic process and pinching off of the toxin containing clathrin-coated
vesicle requires both actin and dynamin.
doi:10.1371/journal.ppat.1000792.g009
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off and detach through the action of the GTPase dynamin and
of actin.
Materials and Methods
Cells
Hela cells were grown in complete Modified Eagle’s medium
(MEM) (Gibco) supplemented with 10% fetal calf serum (FCS),
2 mM L-glutamine, penicillin and streptomycin. The anthrax
toxin receptor–deficient CHO (here designated as CHO
DATR)
cells were grown in F12 medium as described previously [44,45].
Stable BHK21-tTA/anti-CHC cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) containing
200 ng ml–1 puromycin and 2 mg ml–1 tetracycline [46]. To
induce CHC antisense RNA expression, tetracycline was removed
from the medium for 48 hours.
Toxins, antibodies and reagents
Anthrax toxin subunits and diphtheria toxin were a gift from S.
Leppla, prepared as described [47], including wild type PA, PA
U7 in which the furin cleavage site RKKR is changed to PGG,
LF. PA63 corresponds to trypsin-nicked PA83 [8]. Antibodies
against anthrax PA were from the Leppla laboratory; the aerolysin
mutant (G202C-I445C) named ASSP was produced in our lab as
described [48]. The rat anti-mouse CMG2 was generated by
genetic immunization with the mouse CMG2 construct (out-
sourced to Genovac). The antibody against the N-terminal peptide
of MEK1 was produced in our laboratory; anti-HA, anti-GFP
monoclonals and anti-HA-agarose conjugated beads from Roche
(Applied Science, IN); anti-tubulin, anti-AP1, anti-vinculin, anti-
talin, anti-MYH9 and anti-b arrestin from Sigma; anti-actin from
Millipore; anti-EF2, anti-Cbl, anti-AP2, anti-caveolin, anti-Ubiq-
uitin from Santa Cruz; anti-GRB2 from BD Transduction
Laboratories; anti-Dab2 from Abcam laboratories, anti-CHC
from Affinity Bioreagents, anti-transferrin receptor from Zymed,
anti-caveolin from Santa Cruz, anti-rab 5 was kindly provided by
J. Gruenberg. Mouse and rabbit HRP secondary antibodies were
from Pierce, IL, rat HRP secondary antibodies were from Sigma
and Alexa-conjugated secondary antibodies from Molecular
Probes. Latrunculin A was purchased from Invitrogen and used
at a final concentration of 0.4 mg/ml for 45 min in medium
without serum at 37uC. Blebbistatin was purchased from Sigma
and used at a final concentration of 50 mM for 1 hr in medium
without serum at 37uC.
Plasmids and transfection
Human TEM8-HA/1, TEM8-HA/2 and CMG2-4-HA were
cloned in pIREShyg2 as described [11]. The human TEM8/1-
GFP (isoform 1) and the human TEM8/2-GFP (isoform 2) were
cloned in pHS003-EGFP, kindly provided by J. Young. Human
TEM8-HA/1 Y383C was generated by mutagenesis using
Quickchange (Stratagene) reagent with the following primers: 59-
G GTA GAC GCC TCT TAT TGT GGT GGG AGA GGC
GTT GG-39. The human and mouse CMG2 (isoform 4) gene
tagged with a V5 epitope was cloned in pcDNA3.1/V5-HIS-
TOPO expression vector. The human CMG2-GFP (isoform 1)
was cloned in pHS003-EGFP as described [49].
Synthetic genes were synthesized by Geneart: CTT for
extracellular part of CMG2 (amino acids 1 to 318) and trans-
membrane and cytosolic regions of TEM8 (amino acids 321 to
573), CCT for extracellular and transmembrane regions of CMG2
(amino acids 1 to 341) and cytosolic part of TEM8 (amino acids
344 to 573) and cloned in pIREShyg2 with a HA tag at the C-
terminus. The human Eps15 gene was cloned in pEGFP-C2,
kindly provided by A. Dautry-Varsat (Pasteur Institute). Plasmids
were transfected into Hela cells for 48 or 72 hrs (2 mg cDNA/
9.6 cm
2 plate) using Fugene (Roche Diagnostics Corporation).
RNAi experiments
siRNA target sequences were the following: human CHC:
GGCCCAGGT GGTAATCATTTT, Grb2: AAGTTTGGAA-
ACGATGTGCAG, NEDD4: ATGGAGTTGATTAGATTA-
CAA, Dynamin II: CTGCAGCTCATCTTCTCAAAA, EPS15:
GTGGACCAACATAATATTAAA, AP1 m subunit: AAGGC-
ATCAAGTATCGGAAGA, AP1 c subunit: AACGAATGTT-
CGGATGACTTT, AP2 m subunit: GGAAAACATCAAGAA-
CAATTT, b-arrestin 1: AAAGCCTTCTGCGCGGAGAAT, b-
arrestin 2: AAGGACCGCAAAGTGTTTGTG, DAB2: AAGG-
TTGGCCTTAGTAGTCAA, were purchased from Qiagen. Cbl
siRNA was purchased from Santa Cruz (sc-29242). As control
siRNA we used the following target sequence of the viral
glycoprotein VSV-G: ATTGAACAAACGAAACAAGGA. To do
silencing, Hela cells were transfected for 72 hours with 100 pmol/
9.2 cm
2 dish of siRNA using oligofectamine (Invitrogen) transfec-
tion reagent.
Total cell extracts, in vitro acid pulse and western blot
analysis
Hela cells were harvested, washed with PBS and homogenized
by passage through a 22G injection needle in HB (HB: 2.9 mM
imidazole and 250 mM sucrose, pH 7.4) containing the Roche
mini tablet protease inhibitors cocktail following manufacturer’s
instructions. To convert surface PA
7mer to an SDS-resistant form,
cell extracts were incubated at room temperature for 10 min with
145 mM NaCl and 20 mM MES-Tris, pH 4.5. Protein quantifi-
cation was done with Pierce BCA kit. Proteins were loaded at
40 mg prot/lane and separated on a 4–20% acrylamide precast
Novex gel (Invitrogen) under reducing conditions for PA and
native condition for diphtheria toxin and transferred to nitrocel-
lulose membranes (Schleicher and Schuell).
Immunoprecipitation
For immunoprecipitations, cells were lysed 30 min at 4uCi nI P
buffer (0.5%NP40, 500 mM NaCl, 500 mM Tris-HCl pH 7.4,
20 mM EDTA, 10 mM NaF, 2 mM benzamidine, and a cocktail
of protease inhibitors, Roche), centrifuged 3 min at 2000 g and
supernatants were incubated 16 h at 4uC with antibodies and
beads.
To follow protein Ubiquitination, 1 mM of NEM was added in
the lysis buffer described above.
Flow cytometric analysis
BHK or Hela cells were incubated one hour at 4uC with 1 ug/
ml PA63, washed and incubated different times at 37uC, washed at
4uC and incubated 5 min on ice with cold trypsin. Loosely
attached cells were harvested by pipetting and stained for 30 min
on ice with anti-PA antibodies, followed stained for 30 min on ice
with secondary fluorescent antibodies, washed in PBS+1%FCS
and then evaluated on a FACSCalibur
TM (Becton Dickinson).
FACS data were analyzed using FlowJo software (FlowJo, LLC).
Fluorescence recovery after photobleaching (FRAP)
HeLa cells were seeded and transfected with GFP-tagged
receptors in 35 mm glass bottom dishes (MatTek). Samples were
analyzed on a Leica SP2 confocal scanning microscope using a
63x oil immersion objective. After 10 scans of a chosen region a
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bleached using the full power of the 488, 458 and 476 nm laser
lines. The bleaching resulted in a ,80% depletion of fluorescence.
Recovery of fluorescence was monitored over 80 seconds with a 2
second interval by scanning the region with a low 488 nm laser
power to minimize photobleaching during sampling. The
fluorescence of the bleached area was normalized at each time
point using a non-bleached control area. Recovery kinetics were
fitted to an exponential function.
Supporting Information
Figure S1 Endocytosis of the anthrax toxin is clathrin mediated.
A: The efficiency of the different siRNAs used in the study was
analyzed on cell extracts (40 mg of proteins) by SDS-PAGE and
western blotting. B: Stable BHK21-tTA/anti-CHC cells were
maintained in 2 mg/ml tetracycline (control cells). To induce CHC
antisense RNA expression (CHC AS), tetracycline was removed
from the medium for 48 hrs. Control and CHC AS cells were
treated with 1 mg/ml of PA63 for 1 hr at 4uC (red) and 5 min at
37uC (green). Cells were prepared for FACS analysis. C: Hela cells
were transfected 72 hrs with human CMG2-V5 and with control
siRNAs or siRNAs against CHC and incubated with 500 ng/ml
PA63 for 1 hr at 4uC and different times at 37uC. Immunopre-
cipitation was performed against CMG2-V5 and samples were
analyzed by SDS-PAGE and western blotting to reveal the
different forms of PA.
Found at: doi:10.1371/journal.ppat.1000792.s001 (0.27 MB PDF)
Figure S2 Diphtheria toxin enters cells via a clathrin and AP-2
dependent route that does not require actin. A-B: Hela cells were
or not transfected for 72 hrs with the pSuper vector containing the
human CHC (A) or with RNAi oligonucleotide control siRNAs or
siRNAs against the m chains of AP-1 or AP-2 (B). Cells were
incubated with 500 ng/ml of trypsin-nicked DT different times at
37uC in serum free medium and extracts (40 mg of proteins) were
analyzed by Native or SDS-PAGE and western blotting to reveal
EF2. C: Hela cells were treated 45 min at 37uC or not with
Latrunculin A. Cells were then treated in the presence or absence
of Latrunculin A with 500 ng/ml of trypsin-nicked DT different
times at 37uC in serum free medium. Cell extracts were prepared
and the modification of EF2 analyzed on native or SDS-PAGE
(40 mg of proteins).
Found at: doi:10.1371/journal.ppat.1000792.s002 (0.48 MB PDF)
Figure S3 Endocytosis of the anthrax toxin depends on AP1 but
not Nedd4 and AP2. A: Hela cells were transfected 72 hrs with
control siRNAs or siRNAs against m chains of AP-1 or AP-2. Cells
were incubated directly at 37uC with 500 ng/ml PA63 and
100 ng/ml LF for different times. 40 mg of proteins were analyzed
by SDS-PAGE and western blotting to reveal PA63 and SDS-
resistant heptamer (pPA
7mer). B: Hela cells were transfected 72 hrs
with control siRNAs or siRNAs against Nedd4, m chains of AP-1
or c chains of AP-1. Cells were incubated with 500 ng/ml PA63
and 100 ng/ml LF for 1 hour at 4uC and different times at 37uC.
40 mg of proteins were analyzed by SDS-PAGE and western
blotting to reveal PA63 and SDS-resistant heptamer (pPA
7mer). C:
Hela cells were transfected 72 hrs with control siRNAs or siRNAs
against CHC, m chains of AP-1 or b-arrestin1 (b-Arr1). Cells were
incubated with 500 ng/ml PA63 and 100 ng/ml LF for 1 hour at
4uC and different times at 37uC and cell extracts were submitted
to a pH 4.5 treatment to convert all heptameric PA to an SDS-
resistant form detectable by SDS PAGE. 40 mg of proteins were
analyzed by SDS-PAGE and western blotting to reveal PA.
Found at: doi:10.1371/journal.ppat.1000792.s003 (0.60 MB PDF)
Figure S4 b-arrestin affects ubiquitination of TEM8-1. Hela
cells were transfected 72 hrs with control siRNAs or siRNAs
against AP-1 and b-arrestin-1 (b-Arr-1) and with TEM8/1-HA.
Cells were then treated or not with 1 mg/ml of PA63 WT for 1 hr
at 4uC and different times at 37uC. Immunoprecipitates against
TEM8-HA were analyzed by SDS-PAGE and western blotting
against Ubiquitin, TEM8-HA and PA.
Found at: doi:10.1371/journal.ppat.1000792.s004 (0.38 MB PDF)
Figure S5 Latrunculin A prevents transport of PA to endosomes
and subsequent cleavage of MEK1. Hela cells were treated 45 min
at 37uC with or without Latrunculin A, prior to the addition of
500 ng/ml of PA63 and 100 ng/ml LF for 1 hr at 4uC followed by
different incubation times at 37uC. Cell extracts (40 mg of proteins)
were analyzed by SDS-PAGE and western blotting to reveal
pPA
7mer, PA63 and the N-terminus of MEK1 (MEK1(N)) (see
main Fig. 6) Levels of pPA
7mer and full length MEK1 were
quantified using the Typhoon scanner and normalized to 1 and
100% respectively at time 0 (1 hour at 4uC). The plot represents
the means of 4 independent experiments. Errors represent
standard deviations.
Found at: doi:10.1371/journal.ppat.1000792.s005 (0.40 MB PDF)
Figure S6 The myosin II inhibitor blebbistatin inhibits PA
heptamerization and endocytosis in Hela cells. A-C: Hela cells
were treated 45 min at 37uC with or without blebbistatin, prior to
the addition of 500 ng/ml of PA63 and 100 ng/ml LF for 1 hr at
4uC followed by different incubation times at 37uC. A: Cell
extracts (40 mg of proteins) were analyzed by SDS-PAGE and
western blotting to reveal pPA
7mer and PA63. B: Levels of pPA
7mer
and N-terminus of MEK1 (MEK1(N)). Levels of pPA
7mer and full
length MEK1 were quantified using the Typhoon scanner and
normalized to 1 and 100% respectively at time 0 (1 hour at 4uC).
The plot represents the means of 4 independent experiments.
Errors represent standard deviations. C: Cell extracts obtained in
A were submitted to a pH 4.5 treatment to convert all heptameric
PA63 to an SDS-resistant form prior to SDS-PAGE and western
blotting against PA.
Found at: doi:10.1371/journal.ppat.1000792.s006 (0.36 MB PDF)
Figure S7 TEM8-1 interacts with talin, vinculin and myosin II.
A: Alignment of the cytoplasmic tails of human TEM8 isoforms 1
and 2 and human CMG2 isoform 4 using the SIM software of the
EXPASY server (www.expasy.ch). Regions of identity are shown
in yellow. B: Hela cells were transfected 24 hrs with TEM8/1-HA
or TEM8/2-HA. Immunoprecipitates against TEM8-HA were
analyzed by SDS-PAGE and western blotting against Talin,
Vinculin, TEM8-HA and the blebbistatin sensitive myosin II
heavy chain 9, MyH9. C: Hela cells were transfected 24 hrs with
TEM8/1-HA. Cells were treated 45 min at 37uC with or without
Latrunculin A, prior to the addition or not of 500 ng/ml of PA63
for 1 hr at 4uC and 10 minutes at 37uC. Cells were solubilized in
1% Triton-X-100 at 4uC, loaded at the bottom of an Optiprep
gradient, and 6 fractions were collected from the top and analyzed
by SDS-PAGE and western blotting against Tem8-HA, PA,
Transferrin Receptor (Trf-R) and Caveolin 1 (Cav-1).
Found at: doi:10.1371/journal.ppat.1000792.s007 (0.24 MB PDF)
Figure S8 CMG2 mediated PA endocytosis is latrunculin
dependent. CHO
DATR cells were transfected 48 hrs with CMG2/
1-GFP. Cells were treated 45 min at 37uC or not with Latrunculin
A in serum free medium. Cells were then treated in the presence or
absenceofLatrunculinAwith1 ug/mlofPA63for1 hrat4uC(red)
and incubated 20 minutes at 37uC (blue), and subsequently
submitted to FACS analysis. Only GFP positive cells were gated.
Found at: doi:10.1371/journal.ppat.1000792.s008 (0.21 MB PDF)
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